Santen Pharmaceutical Stock price
Compare with Peer Group
Is Santen Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Santen Pharmaceutical Stock Analysis
Analyst Opinions
13 Analysts have issued a Santen Pharmaceutical forecast:
Analyst Opinions
13 Analysts have issued a Santen Pharmaceutical forecast:
Don't miss a Thing! We will send you all news about Santen Pharmaceutical directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Santen Pharmaceutical Stock News
Company Profile
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,744 full-time employees. The firm has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The firm engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The firm operates in Japan, Europe, Asia, North America markets.
| Head office | Japan |
| CEO | Mr. Ito |
| Employees | 3,849 |
| Website | www.santen.com |


